Cold agglutinin disease revisited: a multinational, observational study of 232 patients.

Autor: Berentsen S; Department of Research and Innovation, Haugesund Hospital, Helse Fonna Hospital Trust, Haugesund, Norway., Barcellini W; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., D'Sa S; Cancer Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Randen U; Department of Pathology, Akershus University Hospital, Lørenskog, Norway., Tvedt THA; Department of Medicine, Haukeland University Hospital, Bergen, Norway., Fattizzo B; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy., Haukås E; Department of Blood and Cancer Diseases, Stavanger University Hospital, Stavanger, Norway., Kell M; Cancer Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Brudevold R; Department of Medicine, Ålesund Hospital, Helse Møre og Romsdal Hopspital Trust, Ålesund, Norway., Dahm AEA; Department of Haematology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Dalgaard J; Department of Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway., Frøen H; Department of Medicine, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway., Hallstensen RF; Department of Medicine, Nordland Hospital, Bodø, Norway., Jæger PH; Department of Hematology, St Olav University Hospital, Trondheim, Norway.; Faculty of Medicine and Health Sciences and., Hjorth-Hansen H; Department of Hematology, St Olav University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Małecka A; Department of Haematology and.; Department of Pathology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo Norway., Oksman M; Department of Internal Medicine, Turku City Hospital, Turku, Finland.; Department of Hematology and Stem Cell Transplantation, Turku University Hospital, Turku, Finland., Rolke J; Department of Medicine, Sørlandet Hospital, Kristiansand, Norway., Sekhar M; Haematology Department, Royal Free London NHS Foundation Trust, London, United Kingdom., Sørbø JH; Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Norway; and., Tjønnfjord E; Department of Internal Medicine, Østfold Hospital Trust, Grålum, Norway., Tsykunova G; Department of Medicine, Haukeland University Hospital, Bergen, Norway., Tjønnfjord GE; Department of Haematology and.; KG Jebsen Centre for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo Norway.

Publikováno v: Blood [Blood] 2020 Jul 23; Vol. 136 (4), pp. 480-488.

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial.

Autor: Berentsen S; Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway., Randen U; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Department of Pathology, Akershus University Hospital, Lørenskog, Norway., Oksman M; Department of Hematology and Stem Cell Transplantation, Division of Medicine, Turku University Hospital, Turku, Finland.; Department of Internal Medicine, Turku City Hospital, Turku, Finland., Birgens H; Department of Haematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Tvedt THA; Department of Medicine, Haukeland University Hospital, Bergen, Norway.; Section for Hematology, Department of Clinical Science, University of Bergen, Bergen, Norway., Dalgaard J; Medical Department, Drammen Hospital, Vestre Viken Trust, Drammen, Norway., Galteland E; Department of Medicine, Akershus University Hospital, Lørenskog, Norway.; Department of Haematology, Oslo University Hospital, Oslo, Norway., Haukås E; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Brudevold R; Department of Medicine, Ålesund Hospital, Ålesund, Norway., Sørbø JH; Department of Medicine, Levanger Hospital, Levanger, Norway., Næss IA; Department of Hematology, St Olav University Hospital, Trondheim, Norway., Malecka A; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway; and., Tjønnfjord GE; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Publikováno v: Blood [Blood] 2017 Jul 27; Vol. 130 (4), pp. 537-541. Date of Electronic Publication: 2017 May 22.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[High-dose treatment with autologous stem cell support in a Norwegian region].

Autor: Hammerstrøm J; St. Olavs Hospital, 7600 Trondheim. jens.hammerstrom@medisin.ntnu.no, Aasland IL, Telhaug R, Moen T, Lødemel B, Sørum Y, Brudevold R, Herlofsen O, Sørbø JH, Almvik T, Lamvik J

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2004 Oct 07; Vol. 124 (19), pp. 2498-500.

Halting targeted and collateral damage to red blood cells by the complement system.

Autor: Jalink, M.^1,2 (AUTHOR), de Boer, E. C. W.^3,4 (AUTHOR), Evers, D.⁵ (AUTHOR), Havinga, M. Q.³ (AUTHOR), Vos, J. M. I.^2,6,7 (AUTHOR), Zeerleder, S.^3,8,9 (AUTHOR), de Haas, M.^1,7,10 (AUTHOR), Jongerius, I.^3,4 (AUTHOR) i.jongerius@sanquin.nl

Publikováno v: Seminars in Immunopathology. Dec2021, Vol. 43 Issue 6, p799-816. 18p.